T-PSA (Total-Prostate Specific Antigen)

T-PSA (Total-Prostate Specific Antigen)


Negotiable Min Order Quantity Unit

Required Quantity
Place of Origin
China
Payment Terms
Negotiable
Production method
Negotiable
Shipping / Lead Time
Negotiable / Negotiable
Keyword
diagnostic reagent, cancer diagnosis, tumor marker
Category
Medical Devices

Tellgen corporation

Membership
BIZ
Country / Year Established
China China / 2003
Business type
Manufacturer
Verified Certificate

9

Product name T-PSA (Total-Prostate Specific Antigen) Certification -
Category Medical Devices Ingredients -
Keyword diagnostic reagent , cancer diagnosis , tumor marker Unit Size -
Brand name - Unit Weigh -
origin China Stock -
Supply type - HS code -

Product Information

 

PSA: (free PSA and total PSA)

Compitable instrument: Luminex 200,TESMI F4000 .

The kit’s detection reference value is 4.0ng/ml  for total PSA and 1ng/ml for free PSA.

Tellgen also provide following Tumor markers and Tumor Marker control :

CA125

CA153

CA24-2

CYFRA21-1

AFP

CEA 

CEA

total PSA

free PSA

free-beta-hCG

CA19-9

NSE

SCCA

CA72-4

CA50

HE4

ProGRP

PGI/PGII

Control 1

Control 2

Control 3

 

What is the PSA test?

 

Prostate-specific antigen, or PSA, is a protein produced by cells of the prostate gland. The PSA test measures the level of PSA in a man’s blood. For this test, a blood sample is sent to a laboratory for analysis. The results are usually reported as nanograms of PSA per milliliter (ng/mL) of blood.

 

The blood level of PSA is often elevated in men with prostate cancer, and the PSA test was originally approved by the FDA in 1986 to monitor the progression of prostate cancer in men who had already been diagnosed with the disease. In 1994, the FDA approved the use of the PSA test in conjunction with a digital rectal exam (DRE) to test asymptomatic men for prostate cancer. Men who report prostate symptoms often undergo PSA testing (along with a DRE) to help doctors determine the nature of the problem.

 

In addition to prostate cancer, a number of benign (not cancerous) conditions can cause a man’s PSA level to rise. The most frequent benign prostate conditions that cause an elevation in PSA level are prostatitis (inflammation of the prostate) and benign prostatic hyperplasia (BPH) (enlargement of the prostate). There is no evidence that prostatitis or BPH leads to prostate cancer, but it is possible for a man to have one or both of these conditions and to develop prostate cancer as well.

 

 

How is the PSA test used in men who have been treated for prostate cancer?

 

The PSA test is used to monitor patients who have a history of prostate cancer to see if their cancer has recurred (come back). If a man’s PSA level begins to rise after prostate cancer treatment, it may be the first sign of a recurrence. Such a “biochemical relapse” typically appears months or years before other clinical signs and symptoms of prostate cancer recurrence.

 

However, a single elevated PSA measurement in a patient who has a history of prostate cancer does not always mean that the cancer has come back. A man who has been treated for prostate cancer should discuss an elevated PSA level with his doctor. The doctor may recommend repeating the PSA test or performing other tests to check for evidence of a recurrence. The doctor may look for a trend of rising PSA level over time rather than a single elevated PSA level.

 

 

 

B2B Trade

Price (FOB) Negotiable transportation -
MOQ Negotiable Leadtime Negotiable
Payment Options Negotiable Shipping time Negotiable

Tellgen corporation

Country / Year Established
China China / 2003
Membership
BIZ
Business type
Manufacturer

9

President
Yao Jiaoer
Address
Building 1, No.115, Lane 572, Bibo road, Free trade area
Product Category
Other Monitoring & Diagnostic Equipment
Year Established
2003
No. of Total Employees
101-500
Company introduction

Shanghai Tellgen Corporation. was founded in 2003 and dedicated exclusively to the development, production and distribution of high-quality automated workflow solutions for research and clinical diagnostics laboratories in the life sciences sector. With the tremendous development, Tellgen became the the market leader in moleucular diagnosis area, and had consistently delivered series diagnostic products for healthcare 

Main Product

Related Products

Other buyers also search

Membership Grade

BUYER

Biz Pro VIP

SELLER

Biz Pro VIP
팝업닫기
Live Chat A new message arrives
from a business partner.

No Data

  • There is no data to load
  • Check out the My TK > My Inquiries list.
  • After agreeing to the use of the Live Chat service, the list is printed only when there is at least one history of receiving or sending a Live Chat request.

If you have not yet agreed to use the Live Chat service,

You can use the Live Chat freely after agreeing to the use of the Live Chat service.

View more
View more